Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000426627 | SCV000519126 | likely benign | not specified | 2015-10-26 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV000560212 | SCV000645855 | likely benign | Dilated cardiomyopathy 1W | 2023-10-04 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004022333 | SCV004977999 | uncertain significance | Cardiovascular phenotype | 2021-06-24 | criteria provided, single submitter | clinical testing | The c.2748G>A (p.P916P) alteration is located in exon 19 (coding exon 19) of the VCL gene. This alteration consists of a G to A substitution at nucleotide position 2748. This nucleotide substitution does not change the amino acid at codon 916. However, this change occurs in the last nucleotide of Exon 19 (c.2746_2949) which makes it likely to have some effect on normal mRNA splicing. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |